By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Response today announced a joint research and development deal with Scripps Genomic Medicine targeting oncology and cardiovascular disease.

The deal calls for Molecular Response to fund up to two discovery programs in the two indications. In return, Scripps will grant the San Diego-based firm exclusive intellectual property rights.

Further financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Nov
14
Sponsored by
PerkinElmer

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.